ClinConnect ClinConnect Logo
Search / Trial NCT02275000

Feasibility Study of Physiotherapy for Functional Motor Symptoms

Launched by UNIVERSITY COLLEGE, LONDON · Oct 22, 2014

Trial Information

Current as of June 15, 2025

Completed

Keywords

ClinConnect Summary

Participants will be recruited from outpatient neurology clinics at Queen Square. Those who consent to take part will complete baseline outcome measures (Time 1) before being randomised to either a Treatment as Usual control group or the Intervention group.

Treatment as Usual group -

1. Participants will be directed to online patient information resources (www.neurosymptoms.org)
2. Participants will be placed on the waiting list to be assessed for the inpatient treatment programme for functional symptoms at The National Hospital for Neurology and Neurosurgery. The waitlist is currently gr...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • A clinically established diagnosis of functional motor symptoms according to the Fahn-Williams criteria.
  • Diagnostic investigations have come to an end.
  • The patient accepts the diagnosis of functional motor symptoms.
  • Symptom duration of at least six months.
  • Symptoms must be sufficient to cause significant distress (subjectively described by the patient) or impairment in social, occupational or other important areas of functioning.
  • Exclusion Criteria:
  • Unable to understand English.
  • Pain, fatigue or dissociative seizures is the predominant symptom.
  • Prominent untreated axis 1 disorders (e.g. anxiety or depression).
  • Level of disability prevents participation in a 5 day outpatient programme (Barthel Index score less than 25/100)
  • Patient unable to attend 5 consecutive days.

About University College, London

University College London (UCL) is a leading global research institution renowned for its commitment to advancing healthcare through innovative clinical trials. As a prominent sponsor of clinical research, UCL leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous investigations aimed at improving patient outcomes and addressing pressing medical challenges. The institution fosters collaboration among researchers, healthcare professionals, and industry partners, ensuring that its trials adhere to the highest ethical standards and regulatory guidelines. UCL's dedication to translating scientific discoveries into practical applications underscores its role as a vital contributor to the advancement of medical science and public health.

Locations

London, , United Kingdom

Patients applied

0 patients applied

Trial Officials

Glenn Nielsen

Principal Investigator

UCL

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials